ReShape Lifesciences Inc. today announces that the United States Patent and Trademark Office ("USPTO") has issued an Issue Notification for U.S. Patent Number 10010441 entitled "Gastric Restriction Device for
ReShape Lifesciences Inc. announced today that their ReShape Integrated Dual Balloon technology has been granted employee coverage through a supplemental coverage policy at a multinational telecommunications corporation that provides mobile telephone, fixed telephone and broadband subscription television services.
ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced new data that was presented this week at the ObesityWeek 2017 conference in Washington D.C.
According to a report by the U.S. Centers for Disease Control and Prevention (CDC), about 630,000 people in the United States were diagnosed with a cancer associated with being overweight or obese in 2014.
A new study published by The Obesity Society finds that being overweight can lead to financial costs. This is largely due to the need for more medical costs and loss of productivity caused by obesity.
Often, when we talk to new patients and ask them to describe their nutritional goals, they say they want to be thin and stay thin. But a new article recently published in The New York Times suggests that individuals who are trying to shed pounds no longer want to talk about “dieting” and “weight loss.”